Primary cutaneous B-cell lymphoma: report of eight cases and review of the literature.
Vural
Filiz
F
Department of Hematology, Medical Faculty, Ege University, Izmir, Turkey. fivural@yahoo.com
Saydam
Guray
G
Cagirgan
Seckin
S
Ertekin
Banu
B
Hekimgil
Mine
M
Unal
Idil
I
Soydan
Saliha
S
Tombuloglu
Murat
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols; D001707:Biopsy, Needle; D003131:Combined Modality Therapy; D003520:Cyclophosphamide; D004317:Doxorubicin; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D016393:Lymphoma, B-Cell / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011239:Prednisolone; D018714:Radiotherapy, Adjuvant; D018570:Risk Assessment; D012878:Skin Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D016019:Survival Analysis; D016896:Treatment Outcome; D014750:Vincristine
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone